Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report)’s share price was up 272% during trading on Wednesday . The company traded as high as $0.65 and last traded at $0.65. Approximately 8,500 shares traded hands during mid-day trading, a decline of 5% from the average daily volume of 8,994 shares. The stock had previously closed at $0.18.
Ascletis Pharma Trading Up 272.0 %
The company has a fifty day moving average price of $0.24 and a 200 day moving average price of $0.19.
Ascletis Pharma Company Profile
Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis.
Further Reading
- Five stocks we like better than Ascletis Pharma
- 3 Stocks to Consider Buying in October
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is a Death Cross in Stocks?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Investing In Automotive Stocks
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
